215 related articles for article (PubMed ID: 8903422)
1. Effect of growth factors on estrogen receptor mediated gene expression.
Hafner F; Holler E; von Angerer E
J Steroid Biochem Mol Biol; 1996 Jul; 58(4):385-93. PubMed ID: 8903422
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors.
Ram PT; Kiefer T; Silverman M; Song Y; Brown GM; Hill SM
Mol Cell Endocrinol; 1998 Jun; 141(1-2):53-64. PubMed ID: 9723886
[TBL] [Abstract][Full Text] [Related]
3. Ligand-independent activation of steroid receptors.
Flint AP; Sheldrick EL; Fisher PA
Domest Anim Endocrinol; 2002 Jul; 23(1-2):13-24. PubMed ID: 12142222
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I.
Aronica SM; Katzenellenbogen BS
Mol Endocrinol; 1993 Jun; 7(6):743-52. PubMed ID: 7689695
[TBL] [Abstract][Full Text] [Related]
5. EGF activates highly selective estrogen-responsive reporter plasmids by an ER-independent pathway.
Gehm BD; McAndrews JM; Jordan VC; Jameson JL
Mol Cell Endocrinol; 2000 Jan; 159(1-2):53-62. PubMed ID: 10687852
[TBL] [Abstract][Full Text] [Related]
6. Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells.
Lee AV; Weng CN; Jackson JG; Yee D
J Endocrinol; 1997 Jan; 152(1):39-47. PubMed ID: 9014838
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
8. Role of insulin-like growth factor-I in regulating estrogen receptor-alpha gene expression.
Stoica A; Saceda M; Fakhro A; Joyner M; Martin MB
J Cell Biochem; 2000 Jan; 76(4):605-14. PubMed ID: 10653980
[TBL] [Abstract][Full Text] [Related]
9. Estrogen- and antiestrogen-responsiveness of HEC1A endometrial adenocarcinoma cells in culture.
Castro-Rivera E; Safe S
J Steroid Biochem Mol Biol; 1998 Mar; 64(5-6):287-95. PubMed ID: 9618030
[TBL] [Abstract][Full Text] [Related]
10. Cyr61, a member of the CCN family, is required for MCF-7 cell proliferation: regulation by 17beta-estradiol and overexpression in human breast cancer.
Sampath D; Winneker RC; Zhang Z
Endocrinology; 2001 Jun; 142(6):2540-8. PubMed ID: 11356703
[TBL] [Abstract][Full Text] [Related]
11. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
Read LD; Greene GL; Katzenellenbogen BS
Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
[TBL] [Abstract][Full Text] [Related]
12. The oestrogen receptor modulates growth of pituitary tumour cells in the absence of exogenous oestrogen.
Newton CJ; Trapp T; Pagotto U; Renner U; Buric R; Stalla GK
J Mol Endocrinol; 1994 Jun; 12(3):303-12. PubMed ID: 7916969
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional activation of cathepsin D gene expression by growth factors.
Wang F; Duan R; Chirgwin J; Safe SH
J Mol Endocrinol; 2000 Apr; 24(2):193-202. PubMed ID: 10750020
[TBL] [Abstract][Full Text] [Related]
14. Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen.
Herman ME; Katzenellenbogen BS
J Steroid Biochem Mol Biol; 1996 Oct; 59(2):121-34. PubMed ID: 9010327
[TBL] [Abstract][Full Text] [Related]
15. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.
Cho H; Katzenellenbogen BS
Mol Endocrinol; 1993 Mar; 7(3):441-52. PubMed ID: 7683375
[TBL] [Abstract][Full Text] [Related]
16. The unliganded estrogen receptor (ER) transduces growth factor signals.
Newton CJ; Buric R; Trapp T; Brockmeier S; Pagotto U; Stalla GK
J Steroid Biochem Mol Biol; 1994 Apr; 48(5-6):481-6. PubMed ID: 8180109
[TBL] [Abstract][Full Text] [Related]
17. Permissive role of polyamines in the cooperative action of estrogens and insulin or insulin-like growth factor I on human breast cancer cell growth.
Huber M; Poulin R
J Clin Endocrinol Metab; 1996 Jan; 81(1):113-23. PubMed ID: 8550737
[TBL] [Abstract][Full Text] [Related]
18. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol.
Ignar-Trowbridge DM; Pimentel M; Parker MG; McLachlan JA; Korach KS
Endocrinology; 1996 May; 137(5):1735-44. PubMed ID: 8612509
[TBL] [Abstract][Full Text] [Related]
19. Estrogenic activity is increased for an antiestrogen by a natural mutation of the estrogen receptor.
Levenson AS; Catherino WH; Jordan VC
J Steroid Biochem Mol Biol; 1997 Mar; 60(5-6):261-8. PubMed ID: 9219916
[TBL] [Abstract][Full Text] [Related]
20. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
Sengupta K; Banerjee S; Saxena N; Banerjee SK
Int J Oncol; 2003 Mar; 22(3):609-14. PubMed ID: 12579315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]